HSIC

Q: What is the price of Henry Schein (HSIC) today?

The price of Henry Schein (HSIC) today is R$ 374,31, with a variation of -2.6% compared to the last year. The price of Henry Schein (HSIC) started the year trading around R$ 375,06 and today it is at R$ 374,31. Follow the real-time price chart, the historical price of Henry Schein (HSIC), and stock data from Ibovespa and international markets.

Q: When does Henry Schein (HSIC) pay dividends?

Henry Schein (HSIC) did not distribute dividends in the last year.

Q: Henry Schein (HSIC) is it worth it?

Currently, Henry Schein (HSIC) is priced at R$ 374,31, with a P/E of 21,83%, representing a deviation of 21,07% from its historical average P/E. In the last year, the stock showed a variation of -2.6% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was -2,60%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy shares of Henry Schein (HSIC)?

Investing in shares of Henry Schein (HSIC) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 shares of Henry Schein (HSIC) yield today?

The yield of Henry Schein (HSIC) was -3,36% in the last month, -2,60% in the last year and 3,94% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 shares of Henry Schein (HSIC) today, the total investment would be based on the current price of R$ 374,31.If past performance were to repeat, the return on your investment would be:In 1 year: R$ 36.457,33In 5 years: R$ 38.905,28In 10 years: 37.808,57It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Henry Schein Inc.

Price

US$ 69,06

variation (12m)

-2,60%

p/l

21,83

p/vp

1,73

DIVIDEND YIELD

0,00%

quote HSIC

BVMF

HSIC

If you had invested

year ago

6 months

1 year

5 years

10 years

today you would have

today you would have:

*The figure considers the reinvestment of dividends.

profitability of HSIC

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

-3,36%

3 months

-5,91%

1 year

-2,60%

2 years

-11,45%

5 years

3,94%

10 years

1,01%

real profitability

profitability minus inflation.

1 month

-3,36%

3 months

-6,38%

1 year

-7,46%

2 years

-19,28%

5 years

-24,05%

10 years

-40,12%

Indicators HSIC

check out the fundamentals of Henry Schein shares

P/L

21,83

Sector: -1,52 Industry: -3,80

P/SALES (PSR)

0,66

Sector: 1,99 Industry: 2,90

P/VP

1,73

Sector: 2,16 Industry: 1,76

DIVIDEND YIELD (DY)

0,00%

Sector: - Industry: -

ROA

3,57%

Sector: -26,53% Industry: -56,94%

ROE

7,94%

Sector: -31,21% Industry: -45,34%

ROIC

6,02%

Sector: -404,40% Industry: -420,46%

Net Margin

3,05%

Sector: -26,56% Industry: -32,35%

GROSS MARGIN

31,33%

Sector: 44,49% Industry: 44,86%

OPERATING MARGIN

6,04%

Sector: -23,10% Industry: -30,21%

P/EBITDA

8,96

Sector: 0,07 Industry: -2,60

P/EBIT

12,83

Sector: -1,37 Industry: -3,22

P/ASSETS

0,78

Sector: 1,23 Industry: 1,32

VPA

40,16

Sector: 3,66 Industry: 1,68

LPA

3,19

Sector: -0,80 Industry: -1,22

EQUITY / ASSETS

0,45

Sector: 0,45 Industry: 0,48

CAGR REVENUES 5 YEARS

4,77%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

-0,74%

Sector: - Industry: -

FAIR PRICE OF Henry Schein ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 69,06

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

-22,26%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

HSIC indicators history

DRAG THE FRAME TO SEE MORE DATA

comparator of Stocks

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	Net Margin
LLY	45,25	34,03	75,21%	0,81%	US$ 624,41 B	25,91%
ISRG	65,56	9,52	14,52%	0,00%	US$ 170,94 B	28,51%
TMO	28,71	3,73	13,01%	0,33%	US$ 189,00 B	15,24%
MDT	25,50	0,00	0,00%	3,03%	US$ 118,85 B	13,63%
SNY	11,17	1,55	13,90%	4,31%	US$ 125,86 B	14,83%
CVS	19,92	1,16	5,84%	3,73%	US$ 90,27 B	1,17%
GSK	17,94	4,15	23,12%	4,04%	US$ 80,77 B	10,87%
ABT	15,66	4,31	27,50%	1,81%	US$ 218,97 B	32,43%
NVS	18,12	5,88	32,47%	3,05%	US$ 247,36 B	24,74%
TMDX	56,86	12,81	22,53%	0,00%	US$ 4,07 B	13,49%
HCA	16,35	-78,84	-482,31%	0,68%	US$ 97,60 B	8,21%
BSX	62,73	6,94	11,06%	0,00%	US$ 157,13 B	13,54%
INMD	5,22	1,48	28,44%	0,00%	US$ 933,03 M	44,50%
DHR	44,49	2,90	6,52%	0,56%	US$ 151,86 B	14,21%
IDXX	52,40	35,40	67,57%	0,00%	US$ 51,64 B	24,41%
FMS	20,59	0,91	4,42%	3,07%	US$ 15,03 B	3,41%
HUM	23,00	1,98	8,61%	1,18%	US$ 36,24 B	1,28%
PHG	127,59	2,23	1,75%	3,13%	US$ 26,81 B	1,07%
DXCM	56,42	12,53	22,21%	0,00%	US$ 32,25 B	13,29%

comparison of HSIC with indexes

If you had invested (change) 2 years a year ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

dividend history HSIC dividend history

Current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY Henry Schein

Henry Schein Inc.

Average user rating I10

4.0 (3 people)

Estados Unidos

33 years

Foundation: 1992

1995

Year of debut on the stock exchange - 30 years

19.000

Employees

The Company Henry Schein Inc. (Estados Unidos), is listed on Nasdaq with a market value of $ 8,49 Billions, having a net worth of $ 4,90 Billions.

With a total of 19.000 employees, the company is listed in the sector of Saúde and categorized in industry of Materiais e Equipamentos Médicos.

In the last 12 months the Company had a revenue of $ 12,77 Billions, which generated a profit in the amount of $ 389,00 Milhões.

As for its main indicators, the Company has a P/E ratio of 21,83, a P/B ratio of 1,73 and in the last 12 months the Company did not pay dividends.

The Company is traded in Brazil through the BDR H1SI34, or can be purchased on abroad through the ticker HSIC.

Market value

US$ 8,49 Billions

Net worth

US$ 4,90 Billions

US$ 4.899.000.000,00

Assets

US$ 10,91 Billions

US$ 10.906.000.000,00

Total Number of Shares

122,00 Milhões

122.000.000

Average Daily Trading Volume

US$ 1,87 Million

US$ 1.867.697,56

Sector

Saúde

Industry

Materiais e Equipamentos Médicos

HSIC

HSIC revenue and profits

HSIC results

DRAG THE FRAME TO SEE MORE DATA

HSIC cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

LBPSW - 4D pharma

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 71,55 30,23% (12M)

P/L

19,92

3,73%

ROE

5,84%

P/VP

1,16

CI - Cigna

US$ 300,32 --13,19% (12M)

P/L

16,13

1,91%

ROE

12,41%

P/VP

2,00

CNC - Centene

US$ 28,66 --63,26% (12M)

P/L

7,07

0,00%

ROE

7,47%

P/VP

0,53

HUM - Humana

US$ 298,87 --14,32% (12M)

P/L

23,00

1,18%

ROE

8,61%

P/VP

1,98

SNY - Sanofi

US$ 50,30 --6,73% (12M)

P/L

11,17

4,31%

ROE

13,90%

P/VP

1,55

HCA - HCA Healthcare

US$ 401,96 4,05% (12M)

P/L

16,35

0,68%

ROE

-482,31%

P/VP

-78,84

LLY - Eli Lilly

US$ 736,03 --22,19% (12M)

P/L

45,25

0,81%

ROE

75,21%

P/VP

34,03

LBPSW - 4D pharma

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 71,55 30,23% (12 M)

P/L

19,92

3,73%

ROE

5,84%

P/VP

1,16

CI - Cigna

US$ 300,32 --13,19% (12 M)

P/L

16,13

1,91%

ROE

12,41%

P/VP

2,00

CNC - Centene

US$ 28,66 --63,26% (12 M)

P/L

7,07

0,00%

ROE

7,47%

P/VP

0,53

HUM - Humana

US$ 298,87 --14,32% (12 M)

P/L

23,00

1,18%

ROE

8,61%

P/VP

1,98

SNY - Sanofi

US$ 50,30 --6,73% (12 M)

P/L

11,17

4,31%

ROE

13,90%

P/VP

1,55

HCA - HCA Healthcare

US$ 401,96 4,05% (12 M)

P/L

16,35

0,68%

ROE

-482,31%

P/VP

-78,84

LLY - Eli Lilly

US$ 736,03 --22,19% (12 M)

P/L

45,25

0,81%

ROE

75,21%

P/VP

34,03

Common Questions

What is the price of Henry Schein (HSIC) today?

The price of Henry Schein (HSIC) today is R$ 374,31, with a variation of -2.6% compared to the last year. The price of Henry Schein (HSIC) started the year trading around R$ 375,06 and today it is at R$ 374,31. Follow the real-time price chart, the historical price of Henry Schein (HSIC), and stock data from Ibovespa and international markets.

When does Henry Schein (HSIC) pay dividends?

Henry Schein (HSIC) did not distribute dividends in the last year.

Henry Schein (HSIC) is it worth it?

Currently, Henry Schein (HSIC) is priced at R$ 374,31, with a P/E of 21,83%, representing a deviation of 21,07% from its historical average P/E. In the last year, the stock showed a variation of -2.6% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was -2,60%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy shares of Henry Schein (HSIC)?

Investing in shares of Henry Schein (HSIC) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 shares of Henry Schein (HSIC) yield today?

The yield of Henry Schein (HSIC) was -3,36% in the last month, -2,60% in the last year and 3,94% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.

If you wanted to buy 100 shares of Henry Schein (HSIC) today, the total investment would be based on the current price of R$ 374,31.

If past performance were to repeat, the return on your investment would be:

In 1 year: R$ 36.457,33
In 5 years: R$ 38.905,28
In 10 years: 37.808,57

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

HSIC

Henry Schein Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

profitability of HSIC

check out the fundamentals of Henry Schein shares

P/L

P/SALES (PSR)

P/VP

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

Net Margin

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSETS

VPA

LPA

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years a year ago, today you would have

Current DY: 0,00%

5-year average DY: 0,00%

ABOUT THE COMPANY Henry Schein

Henry Schein Inc.

Estados Unidos

33 years

1995

19.000

PROFIT X PRICE HSIC

HSIC results

HSIC cash flow

evolution of assets - HSIC

HSIC balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

Common Questions

Tudo que o investidor precisa em um só lugar

Pague 2, Leve 3

Anual

Valor total R$ 238,80